According to the report by Expert Market Research (EMR), the global haemoglobinopathies market size is projected to grow at a CAGR of 7.80% between 2024 and 2032. Aided by the presence of advanced healthcare industries and growing awareness regarding hemoglobinopathies, the market is expected to grow significantly by 2032.
Haemoglobinopathies represent a group of inherited disorders characterised by abnormalities in the structure or production of the haemoglobin molecule. The most common and clinically significant conditions among these disorders are Sickle Cell Disease (SCD) and Thalassemia. These conditions are associated with significant morbidity and mortality, particularly in low-income and middle-income countries.
One of the key haemoglobinopathies market trends is the escalating awareness about these disorders and the corresponding growth in newborn and premarital screening programs. Governments, especially in high prevalence areas, are progressively introducing newborn screening as a part of national health policy. For instance, mandatory newborn screening in the United States has made early diagnosis and treatment of SCD possible.
Get a Free Sample Report With Table Of Contents – https://www.expertmarketresearch.com/reports/haemoglobinopathies-market/requestsample
There has been a noteworthy progress in the treatment options available for haemoglobinopathies. Bone marrow or stem cell transplantation offers a potential cure for these disorders, but it is associated with significant risks and costs. Recent years have witnessed remarkable advancements in gene therapy for SCD and Thalassemia, offering the promise of a more accessible cure. These innovative therapies are among the primary drivers for haemoglobinopathies market growth.
Haemoglobinopathies have a widespread prevalence, affecting populations worldwide but are most common in Africa, the Middle East, and South Asia. Migration patterns have also led to increased incidence in North America and Europe. This widespread prevalence ensures a sustained demand for diagnostics, treatments, and support for affected individuals.
North America currently holds a significant haemoglobinopathies market share, owing to the high healthcare expenditure, robust healthcare infrastructure, and established newborn screening programs. Europe follows closely due to similar reasons and increasing migration from high-prevalence regions.
Telemedicine and remote patient monitoring are emerging as important trends in managing patients with haemoglobinopathies, especially in the context of the COVID-19 pandemic. These technologies enable more consistent and less burdensome monitoring of patients, potentially leading to better health outcomes.
Read Full Report With Table Of Contents – https://www.expertmarketresearch.com/reports/haemoglobinopathies-market
Haemoglobinopathies Market Segmentation
The market can be divided based on type, test type, end use, and region.
Market Breakup by Type
- Thalassemia
- Alpha Thalassemia
- Beta Thalassemia
- Sickle Cell Disease
- Others
Market Breakup by Test Type
- Routine Red Blood Cell (RBC) Count
- Genetic Testing
- Haemoglobin by High Performance Liquid Chromatography
- Haemoglobin Isoelectric Focusing (Hb IEF)
- Haemoglobin Electrophoresis (Hb ELP)
- Haemoglobin Solubility Test
- Others
Market Breakup by End Use
- Hospitals
- Diagnostic Laboratories
- Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global haemoglobinopathies market. Some of the major players explored in the report by Expert Market Research are as follows:
- Sanofi
- Bluebird Bio, Inc.
- Emmaus Medical, Inc.
- Prolong Pharmaceuticals, LLC.
- Global Blood Therapeutics, Inc.
- Others
Read More Reports:
Normal Saline for Parenteral Use Market: https://www.expertmarketresearch.com/reports/normal-saline-for-parenteral-use-market
Impulse Ice Cream Market: https://www.expertmarketresearch.com/reports/impulse-ice-cream-market
Europe Membrane Switch Market: https://www.expertmarketresearch.com/reports/europe-membrane-switch-market
South Korea Fashion Influencer Marketing Market: https://www.expertmarketresearch.com/reports/south-korea-fashion-influencer-marketing-market
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: John Millence, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
